Cardiovascular Risks in Autoimmune and Inflammatory Diseases
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 20 October 2025 | Viewed by 37
Special Issue Editors
Interests: autoimmune diseases; inflammation; cardiovascular risk; atherosclerosis; biological therapy; immunomodulatory therapy; lipid metabolism; cardiovascular risk factors; thrombosis; endothelial dysfunction.
Special Issues, Collections and Topics in MDPI journals
Interests: autoimmune diseases; inflammation; cardiovascular risk; atherosclerosis; biological therapy; immunomodulatory therapy; lipid metabolism; cardiovascular risk factors; thrombosis; endothelial dysfunction.
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Autoimmune and inflammatory diseases, such as rheumatoid arthritis, systemic lupus erythematosus, psoriasis, and inflammatory bowel disease, significantly increase the risk of cardiovascular morbidity and mortality, and yet the precise mechanisms remain incompletely understood. Chronic inflammation, immune dysregulation, endothelial dysfunction, and metabolic disturbances accelerate atherosclerosis, promote thrombosis, and increase the risk of acute cardiovascular events. However, current early detection, risk stratification, and preventive and therapeutic strategies are suboptimal.
This Special Issue will bridge the gap between autoimmunity and cardiovascular pathology by exploring novel biomarkers, uncovering mechanistic insights, and assessing the impact of immunomodulatory or biological therapy on cardiovascular risks. We invite original research, reviews, and clinical studies focusing on immune-mediated vascular damage, inflammatory pathways, lipid metabolism, thrombosis, and the impact of immunosuppressive therapies on cardiovascular outcomes.
By showcasing work by experts in cardiology, rheumatology, internal medicine, gastroenterology, and immunology, this Special Issue will advance interdisciplinary collaboration, refine risk stratification, and optimize management strategies. We welcome contributions that can enhance our understanding and improve cardiovascular health in patients with autoimmune and inflammatory diseases.
Prof. Dr. Elena Rezus
Prof. Dr. Ciprian Rezus
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmune diseases
- inflammation
- cardiovascular risk
- atherosclerosis
- biological therapy
- immunomodulatory therapy
- lipid metabolism
- cardiovascular risk factors
- thrombosis
- endothelial dysfunction
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
